Eric Bjerkholt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares changing hands. The stock had previously closed at $24.02. Analyst Ratings Changes MIRM has been the […]

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The company traded as low as $23.14 and last traded at $23.47, with a volume of 36618 shares traded. The stock had previously closed at $24.02. Wall Street Analysts Forecast Growth A number of equities […]

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q4 2023 Earnings Call Transcript February 28, 2024 Mirum Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.66 EPS, expectations were $-0.33. MIRM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]